-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on January 1, Yifang Biotechnology (Shanghai) Co., Ltd. (abbreviation: Yifang Biotech) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CITIC Securities is its sole sponsor. According to the prospectus, Yifang Biotech (688382.SH) is a development-driven biopharmaceutical company based in China with a global layout, focusing on a large number of major diseases such as tumors, autoimmune diseases, and metabolic diseases where there are a large number of unmet needs.

Zhitongcaijing·01/01/2026 23:57:03
Listen to the news
The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on January 1, Yifang Biotechnology (Shanghai) Co., Ltd. (abbreviation: Yifang Biotech) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CITIC Securities is its sole sponsor. According to the prospectus, Yifang Biotech (688382.SH) is a development-driven biopharmaceutical company based in China with a global layout, focusing on a large number of major diseases such as tumors, autoimmune diseases, and metabolic diseases where there are a large number of unmet needs.